@article{429554ffc3e9450ab83afaca6a8b6a91,
title = "Atezolizumab plus bevacizumab: A novel breakthrough in hepatocellular carcinoma",
abstract = "The combination of atezolizumab and bevacizumab increases overall survival compared with sorafenib in advanced hepatocellular carcinoma (HCC). Its approval by the FDAhas launched a newera of combination therapies in advanced and earlier settings that are likely to reshape the management of HCC across all disease stages.",
author = "Florian Castet and Willoughby, {Catherine E.} and Haber, {Philipp K.} and Llovet, {Josep M.}",
note = "Funding Information: F. Castet is supported by a Cl{\'i}nico Junior grant from Fundaci{\'o}n Cient{\'i}fica AECC. C.E. Willoughby is supported by a Sara Borrell Fellowship (CD19/00109) from the Instituto de Salud Carlos III (ISCIII) and the European Social Fund. P.K. Haber is supported by a grant from the German Research Foundation (DFG, HA 8754/1-1). J.M. Llovet is supported by grants from the European Commission (EC) Horizon 2020 Program (HEPCAR, proposal number 667273-2), the U.S. Department of Defense (CA150272P3), the NCI (P30 CA196521), the Samuel Waxman Cancer Research Foundation, the Spanish National Health Institute (MICINN, PID2019-105378RBI00), through a partnership between Cancer Research UK, Fondazione AIRC and Fundaci{\'o}n Cient{\'i}fica de la Asociacion Espa{\~n}ola Contra el C{\'a}ncer (HUNTER, Ref. C9380/A26813), and by the Generalitat de Catalunya (AGAUR, SGR-1358). Funding Information: F. Castet is supported by a Cl?nico Junior grant from Fundaci?n Cient?fica AECC. C.E. Willoughby is supported by a Sara Borrell Fellowship (CD19/00109) from the Instituto de Salud Carlos III (ISCIII) and the European Social Fund. P.K. Haber is supported by a grant from the German Research Foundation (DFG, HA 8754/1-1). J.M. Llovet is supported by grants from the European Commission (EC) Horizon 2020 Program (HEPCAR, proposal number 667273-2), the U.S. Department of Defense (CA150272P3), the NCI (P30 CA196521), the Samuel Waxman Cancer Research Foundation, the Spanish National Health Institute (MICINN, PID2019-105378RBI00), through a partnership between Cancer Research UK, Fondazione AIRC and Fundaci?n Cient?fica de la Asociacion Espa?ola Contra el C?ncer (HUNTER, Ref. C9380/A26813), and by the Generalitat de Catalunya (AGAUR, SGR-1358). Publisher Copyright: {\textcopyright} 2021 American Association for Cancer Research.",
year = "2021",
month = apr,
doi = "10.1158/1078-0432.CCR-20-4706",
language = "English",
volume = "27",
pages = "1827--1829",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "7",
}